Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 topical M119102 safety, tolerability, and pharmacokinetics in healthy adults
jRCT2071220006Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in alopecia areata comparing 10% M119102 topical with M119102 vehicle placebo (2 arms). Primary endpoints: Safety and tolerability of 10% M119102 and Pharmacokinetics of 10% M119102. Started May 2022; status: completed.
02
Drugs
M119102
03
Conditions
alopecia areata
Beyond the preview
Go deeper on jRCT2071220006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071220006.